Attached files

file filename
EX-5.1 - EXHIBIT 5.1 - INTERLEUKIN GENETICS INCv448523_ex5-1.htm
S-1 - S-1 - INTERLEUKIN GENETICS INCv448523_s1.htm

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated March 16, 2016, with respect to the financial statements of Interleukin Genetics, Inc. contained in this Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus and to the use of our name as it appears under the caption “Experts.”

 

/s/ GRANT THORNTON LLP  
   
Boston, Massachusetts  
September 12, 2016